Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature
- PMID: 32902192
- PMCID: PMC7576294
- DOI: 10.1111/jcmm.15672
Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature
Abstract
We generated plasmid pools for the rapid preparation of candidate vaccine strains, which could grow in the Vero cells at low temperature. Firstly, we cloned in the pHW2000 plasmid each of the eight gene segments (PB2, PB1, PA, hemagglutinin [HA], neuraminidase [NA], NS, NP, M) of two master donor strains (MDS), respectively, A/Yunnan/1/2005Vca(H3N2) and B/Yunnan/2/2005Vca(By), which had Vca phenotype (cold-adapted phenotype in Vero cells). Secondly, the similar operation was implemented with each of the HA, NA and NP segments of circulating strains with epidemic potential (parental strains). The virus rescue techniques were employed in this study, according to the homology rate of HA segments between MDS and parental strains. Then, we harvested amount of new Vca virus strains. By transmission electron microscope, it could observe new viruses' diameter and length were from 100 to 120 nm. Importantly, these reassortant viruses could get high-yield production in Vero cells at 25℃ from the beginning to the fourth generation, which was significantly differ from their original parental viruses. Additional, these production 16 new Vca strains could maintain enough antibody binding capacity and attenuation phenotype, which consisted with their MDS. So these plasmid pools constructed by mount of different influenza A and B virus gene fragments could present desired working performance and provide convenience and realization for more Vca reassortant virus as candidate vaccine strain if needing.
Keywords: Vero; high yield; influenza; plasmid pool; vaccine.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The authors confirm that there are no conflicts of interest.
Figures




Similar articles
-
Construction high-yield candidate influenza vaccine viruses in Vero cells by reassortment.J Med Virol. 2016 Nov;88(11):1914-21. doi: 10.1002/jmv.24558. Epub 2016 May 12. J Med Virol. 2016. PMID: 27101353
-
The inactivated vaccine of reassortant H3N2 canine influenza virus based on internal gene cassette from PR8 is safe and effective.Vet Microbiol. 2021 Mar;254:108997. doi: 10.1016/j.vetmic.2021.108997. Epub 2021 Jan 27. Vet Microbiol. 2021. PMID: 33524810
-
Preparation and evaluation of a novel, live, attenuated influenza H1N1 vaccine strain produced by a modified classical reassortment method.Hum Vaccin Immunother. 2018 Mar 4;14(3):615-622. doi: 10.1080/21645515.2017.1380761. Epub 2017 Oct 31. Hum Vaccin Immunother. 2018. PMID: 29064728 Free PMC article.
-
Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.Chin Med J (Engl). 2009 Dec 5;122(23):2880-5. Chin Med J (Engl). 2009. PMID: 20092795
-
Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains.Hum Vaccin Immunother. 2017 Jan 2;13(1):111-116. doi: 10.1080/21645515.2016.1231261. Epub 2016 Sep 20. Hum Vaccin Immunother. 2017. PMID: 27648636 Free PMC article.
Cited by
-
Analysis of the surveillance results of avian influenza in the external environment of huzhou city from 2017 to 2023.PLoS One. 2025 Jul 3;20(7):e0326382. doi: 10.1371/journal.pone.0326382. eCollection 2025. PLoS One. 2025. PMID: 40608765 Free PMC article.
-
Development of amperometric biosensor based on cloned hemagglutinin gene of H1N1 (swine flu) virus.3 Biotech. 2022 Jun;12(6):141. doi: 10.1007/s13205-022-03200-8. Epub 2022 Jun 1. 3 Biotech. 2022. PMID: 35664651 Free PMC article.
References
-
- Puleston RL, Bugg G, Hoschler K, et al. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy. Health Technol Assess. 2010;14(55):1‐82. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous